Pallas vs Hims & Hers: GLP-1 Telehealth Compared

Hims & Hers is one of the largest telehealth brands in the US, and its Weight Loss by Hims program became one of the most-searched GLP-1 telehealth options after launching in 2024. Pallas Health is a newer alternative focused specifically on GLP-1 weight-loss care. Both can put a GLP-1 in your hands — but as of 2026 the two have diverged in ways that matter, especially around compounded medications, membership fees, and how much you can manage yourself. Here's what's actually different.

Pricing on both sides changes often; figures below reflect each platform's published pricing as of mid-2026. Confirm current numbers on both sites before signing up.

The three differences that matter most in 2026

1. Pallas offers FDA-approved brands and clinician-personalized compounded — not just one tier. After its March 2026 Novo Nordisk settlement, Hims is winding compounded down to branded-only (new patients default to branded; full exit expected by mid-2026). Pallas dispenses the FDA-approved brands (Wegovy®, Ozempic®, Zepbound®, Mounjaro®) and, when a clinician decides a brand isn't the right fit, a per-patient compounded preparation. Compounding isn't a downgrade — it's personalization a fixed-dose pen can't do: a titration step the brand doesn't manufacture, or a formulation that adds a supportive vitamin like B12 or glycine when a clinician judges it appropriate. A branded-only platform can't offer that at all.
2. No membership fee at Pallas, and pricing is all-in. Pallas charges no separate membership or platform fee — on compounded plans the price already includes the provider visit, dose adjustments, unlimited messaging, and shipping, and 3-, 6-, and 12-month bundles bring the per-month cost down further. Hims's program prices and membership terms are tier-based and have historically billed the membership separately from displayed medication pricing. The Pallas companion app is free, with no subscription.
3. Care is 100% online and usually asynchronous. In most states there's no scheduled video visit to book — you complete everything online, and you can message your provider directly through the portal anytime, day or night, about side effects, dose questions, or refills. The same portal lets you track orders, request refills, switch plans, manage billing, and cancel — all yourself.

Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.

Quick comparison

What Hims does well

Scale and brand recognition. Hims & Hers is a public company (NYSE: HIMS) with millions of customers across its telehealth stack. The brand is familiar, the app and billing infrastructure are polished, and the support team is large.

Cross-vertical convenience. If you're already on Hims for hair loss, ED, testosterone, or mental health, adding weight loss into the same app is genuinely easy — one login, one billing relationship. Pallas does none of those things; it's GLP-1 weight care only.

Branded pricing and insurance pathways. Through its Novo Nordisk and Eli Lilly partnerships, Hims's branded prices (for example, injectable Wegovy® around $299/month self-pay, Zepbound® around $399/month) plus the Novo savings card and insurance can bring an eligible patient's copay down substantially — in some cases to $0–25/month. Pallas is cash-pay and does not route insurance today, so for an insured patient who wants a specific FDA-approved brand, Hims can win on net cost. We'll say that plainly.

A larger content and app ecosystem. Hims has extensive educational content, tracking, and community features. If you want a product-experience-heavy platform, that's real.

What Pallas does differently

Both tiers, with compounding as personalization — not a knockoff. This is the headline. Hims is exiting compounding; Pallas keeps both pathways. You can get FDA-approved Wegovy®, Ozempic®, Zepbound®, and Mounjaro®, and — when a clinician decides a brand isn't the right fit — compounded semaglutide (weekly injection or daily oral tablet) or compounded tirzepatide, including lower-cost microdose options. The reason a clinician reaches for compounded isn't price; it's fit: a titration step the brand doesn't manufacture, or a per-patient formulation that adds a supportive vitamin like B12 or glycine. A fixed-dose branded pen can't be tailored that way, and a branded-only competitor can't offer it at all.

No membership fee, flat all-in pricing — with bundles that go lower. Compounded plans are one number per medication, the same every month — a flat $269/mo for semaglutide injection, $299/mo for the oral tablet, $359/mo for tirzepatide — with the provider, dose adjustments, messaging, and shipping included. Prefer to save? Lock in a 3-, 6-, or 12-month plan: the 12-month semaglutide-injection bundle works out to about $194/mo ($2,327 billed once, about $901 less than paying monthly). No separate membership line, no program-tier complexity, no surprise charges at dose increases.

Single-category focus. Pallas isn't a men's-health company that added GLP-1 — it's GLP-1-first. For patients who want to be a priority rather than one of a dozen verticals, that focus shows up in provider responsiveness and program design.

A free companion app. The Pallas companion app (Protein & GLP-1 Tracker, on iOS) tracks protein, steps, weight trend, and dose reminders — free, with no subscription, useful whether or not you're a prescription patient.

Everything self-serve in a 100%-online portal. In most states, care is fully asynchronous — no video visit to schedule. Check order status and shipment tracking, request refills, switch plans, update billing, and cancel anytime, all yourself with no phone queue. Best of all, you can message your provider directly through the portal anytime, day or night, about side effects, dose adjustments, or refills, and they respond — typically within a business day.

Pricing: the real comparison

The honest answer depends on which medication you want.

If you want a compounded GLP-1

Pallas offers one; Hims is phasing its out. Pallas's compounded plans are all-in with no membership, and you choose how often you pay:

• Semaglutide injection: $269/mo month-to-month, or bundle to save — $657 for 3 months, $1,194 for 6, or $2,327 for 12 (about $194/mo, roughly $901 less than paying monthly across the year). Provider, dose changes, messaging, and shipping included at every tier.
• Microdose options: from $179/mo for patients prioritizing tolerability or budget.

If you want an FDA-approved brand

Both platforms can prescribe brand-name. Here Hims often wins on net cost for the insured: its manufacturer partnerships and the Novo savings card can drop an eligible patient's branded copay dramatically, and its self-pay branded prices (≈$299/month for injectable Wegovy®) are below Pallas's cash-pay brand pricing. Pallas's advantage on the branded side isn't price — it's the absence of a separate membership fee and a fully self-serve portal. If you're paying cash, compare the brand sticker directly; if you have coverage, Hims's insurance pathway is a real edge.

The honest summary: Pallas wins on still offering compounded, on no membership fee, on all-in transparency, and on self-serve account management. Hims wins on scale, cross-vertical convenience, and — for insured patients who want a specific FDA-approved brand — net medication cost.

The hidden cost: friction

Across either platform, the most underrated cost is the time you lose to friction — delayed shipments, slow responses, stuck prior authorizations. Pallas optimizes hard for response time as a smaller, single-category company; Hims has more total support capacity but slower per-ticket resolution at its volume. Being able to check your own order status and message your provider directly in the portal removes a lot of that friction up front.

Product experience differences

Managing your care

The Pallas portal is built for self-service, and care is 100% online — asynchronous in most states, so there's no video visit to schedule. Order status and tracking, refill requests, plan and cadence switches, billing updates, and self-serve cancellation all happen there, no phone calls. The piece patients value most is direct provider messaging: send a note anytime, day or night, about a side effect, a dose question, or a refill, and your provider replies — usually within a business day. Hims offers account management and messaging inside its broader app; the difference is how much Pallas pushes toward doing everything yourself in one place.

Provider experience

Hims works with a large W-2 and contract provider network; at that scale you're unlikely to see the same provider on repeat visits, which is fine for routine dose management. Pallas works with a smaller provider group, and patients often build a longer relationship with the same provider — useful when managing comorbidities or titration issues.

Intake and qualification

Both use a standard online intake (about 5–10 minutes) followed by provider review, with decisions typically within a business day. Hims's intake ties into its broader app so you can later add other verticals; Pallas's is focused exclusively on GLP-1 weight management.

Pharmacy and shipping

Both use US-licensed pharmacies and ship in discreet packaging; timelines are similar (2–5 business days) and depend on routing and your state.

Who should pick which

Hims is probably the better fit if:

• You want an FDA-approved brand and have insurance that may cover it (or qualify for the Novo savings card)
• You're already a Hims customer for hair, ED, testosterone, or mental health
• You want a polished, app-driven experience with tracking and community features
• Brand familiarity and scale reassure you

Pallas is probably the better fit if:

• You want a clinician's full toolkit — FDA-approved brands and the option of a personalized compounded preparation when a brand's fixed doses or formulation aren't the right fit (Hims is phasing compounded out)
• You don't want a separate membership or platform fee on top of medication
• You prefer flat, all-in pricing — with 3-, 6-, and 12-month bundles that lower the per-month cost
• You want care that's 100% online and asynchronous, with the ability to message your provider directly anytime about symptoms or refills
• You want to manage everything yourself — orders, refills, plan switches, billing — in one portal
• You'd use a free companion app to track protein, steps, and your weight trend

Either works well if:

• You want an FDA-approved brand and have compared the all-in numbers both ways

Switching between platforms

Both support clean transitions. Export your prescription history from your current platform's portal, complete the new intake noting your current medication and dose, and a provider continues or adjusts it. No restart of titration is needed if you haven't been off medication for more than four weeks. For the clinical side of switching molecules, see semaglutide vs tirzepatide; for what the first 90 days feel like, see our first 3 months guide.

References

Platform pricing and program details reflect each company's publicly published terms as of mid-2026 and change frequently — confirm current numbers on each platform's site before enrolling. The regulatory basis for compounded preparations is summarized by the FDA.

1. Hims & Hers. Weight Loss by Hims — program and medication pricing, as published mid-2026.
2. U.S. Food and Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. 2025.

Bottom line: Hims is the bigger brand with a broad product suite, polished app, and strong insurance/partnership pricing on FDA-approved brands. Pallas is GLP-1-focused, charges no membership fee, and gives a clinician the full toolkit — FDA-approved brands plus a personalized compounded preparation when a brand's fixed doses or formulation aren't the right fit. Pricing is all-in with 3-, 6-, and 12-month bundles that lower the per-month cost, care is 100% online and async with anytime provider messaging, and you run everything — orders, refills, plan changes, billing — from one self-serve portal, plus a free companion app. If you want fee-free all-in simplicity or a clinician who can personalize beyond a fixed-dose pen, Pallas fits; if you want branded with insurance help inside a larger ecosystem, Hims fits.